Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genetic Assays is a specialized clinical diagnostic laboratory that provides high-complexity testing services to healthcare providers and clinical trial sponsors. Founded in 1985 and based in Nashville, Tennessee, the company focuses on esoteric testing, including molecular diagnostics, genetics, and specialized chemistry. It serves as a reference laboratory, offering customized assay development and validation for pharmaceutical and biotechnology companies to support drug development and personalized medicine. The company's expertise spans therapeutic drug monitoring and the development of assays for clinical research applications. In December 2016, Genetic Assays was acquired by Aegis Sciences Corporation, which integrated the lab's molecular diagnostic capabilities into its broader healthcare service portfolio. The facility maintains CLIA certification and CAP accreditation to ensure the highest standards of laboratory testing and regulatory compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genetic Assays.